10.1161/JAHA.120.017752 57
Recent IQVIA prescription data suggests demand for oral Wegovy remains stronger than analysts initially expected and well above Lilly's Foundayo, although Barclays noted the figures understate total Foundayo demand because they exclude certain distribution channels
Yes, Wellbutrin has been associated with weight loss in some individuals
But the honest assessment is that the clinical evidence does not support AOD 9604 as an effective standalone weight loss intervention
This is a great option for those struggling to lose the last bit of fat in a particular area
MJ reports receiving lecture honoraria from Novo Nordisk, Eli Lilly, Pfeizer, Amgen, Novartis, Sanofi, Gedeon Richter and Stada and being an advisory board member of Novo Nordisk, Eli Lilly, Amgen and Pfeizer